{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "4398938", "DateCompleted": {"Year": "1972", "Month": "01", "Day": "11"}, "DateRevised": {"Year": "2016", "Month": "10", "Day": "17"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0098-7484", "JournalIssue": {"Volume": "218", "Issue": "7", "PubDate": {"Year": "1971", "Month": "Nov", "Day": "15"}}, "Title": "JAMA", "ISOAbbreviation": "JAMA"}, "ArticleTitle": "The chemotherapy of hypertension.", "Pagination": {"StartPage": "1009", "EndPage": "1015", "MedlinePgn": "1009-15"}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [], "LastName": "Freis", "ForeName": "E D", "Initials": "ED"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "JAMA", "NlmUniqueID": "7501160", "ISSNLinking": "0098-7484"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antihypertensive Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Diuretics"}, {"RegistryNumber": "0", "NameOfSubstance": "Ganglionic Blockers"}, {"RegistryNumber": "26NAK24LS8", "NameOfSubstance": "Hydralazine"}, {"RegistryNumber": "56LH93261Y", "NameOfSubstance": "Methyldopa"}, {"RegistryNumber": "77W477J15H", "NameOfSubstance": "Chlorothiazide"}, {"RegistryNumber": "8B1QWR724A", "NameOfSubstance": "Reserpine"}, {"RegistryNumber": "ZTI6C33Q2Q", "NameOfSubstance": "Guanethidine"}], "MeshHeadingList": [{"QualifierName": ["administration & dosage", "adverse effects", "therapeutic use"], "DescriptorName": "Antihypertensive Agents"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Chlorothiazide"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Diuretics"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Ganglionic Blockers"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Guanethidine"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Hydralazine"}, {"QualifierName": ["complications", "mortality"], "DescriptorName": "Hypertension"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Methyldopa"}, {"QualifierName": [], "DescriptorName": "Morbidity"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Plants, Toxic"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Reserpine"}, {"QualifierName": [], "DescriptorName": "United States"}, {"QualifierName": [], "DescriptorName": "United States Department of Veterans Affairs"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Veratrum"}], "NumberOfReferences": "54"}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1971", "Month": "11", "Day": "15"}, {"Year": "1971", "Month": "11", "Day": "15", "Hour": "0", "Minute": "1"}, {"Year": "1971", "Month": "11", "Day": "15", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["4398938"]}}]}